Epichem CEO, Colin La Galia, resigns

PERTH, AUSTRALIA: PharmAust Limited (ASX: PAA & PAAO), a clinical stage biotechnology company, announced that Colin La Galia, Chief Executive Officer (CEO) of PAA’s subsidiary Epichem, has resigned. La Galia…